Home Other Building Blocks 22972-55-0
22972-55-0,MFCD08705633
Catalog No.:AA002LP4

22972-55-0 | 1,3-Benzenediol, 4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1mg
≥98%
in stock  
$38.00   $26.00
- +
5mg
≥98%
in stock  
$159.00   $111.00
- +
10mg
≥98%
in stock  
$279.00   $195.00
- +
25mg
≥98%
in stock  
$609.00   $426.00
- +
50mg
98%
in stock  
$1,010.00   $707.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA002LP4
Chemical Name:
1,3-Benzenediol, 4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-
CAS Number:
22972-55-0
Molecular Formula:
C21H30O2
Molecular Weight:
314.4617
MDL Number:
MFCD08705633
SMILES:
CCCCCc1cc(O)cc(c1[C@@H]1C=C(C)CC[C@H]1C(=C)C)O
Properties
Computed Properties
 
Complexity:
426  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Rotatable Bond Count:
6  
XLogP3:
6.5  

Literature

Title: Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol.

Journal: Experimental eye research 20120701

Title: Δ(9) -Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells.

Journal: British journal of pharmacology 20120401

Title: Nonpsychotropic cannabinoids, abnormal cannabidiol and canabigerol-dimethyl heptyl, act at novel cannabinoid receptors to reduce intraocular pressure.

Journal: Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 20111001

Title: Effects of abnormal cannabidiol on oxytocin-induced myometrial contractility.

Journal: Reproduction (Cambridge, England) 20100401

Title: N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.

Journal: BMC neuroscience 20100101

Title: Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.

Journal: Journal of natural products 20080801

Title: The orphan receptor GPR55 is a novel cannabinoid receptor.

Journal: British journal of pharmacology 20071201

Title: The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.

Journal: British journal of pharmacology 20071101

Title: Endothelial vasodilatory cannabinoid receptor in the human pulmonary artery: a future option in the therapy of pulmonary hypertension?

Journal: Journal of hypertension 20071101

Title: Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery.

Journal: Journal of hypertension 20071101

Title: Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.

Journal: The Journal of pharmacology and experimental therapeutics 20070601

Title: 2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling.

Journal: European journal of pharmacology 20070322

Title: The synthetic cannabinoid WIN 55,212-2 increases COX-2 expression and PGE2 release in murine brain-derived endothelial cells following Theiler's virus infection.

Journal: Biochemical pharmacology 20060928

Title: Cannabidiol prevents cerebral infarction via a serotonergic 5-hydroxytryptamine1A receptor-dependent mechanism.

Journal: Stroke 20050501

Title: G protein-coupled endothelial receptor for atypical cannabinoid ligands modulates a Ca2+-dependent K+ current.

Journal: The Journal of biological chemistry 20031114

Title: Arachidonylcyclopropylamide increases microglial cell migration through cannabinoid CB2 and abnormal-cannabidiol-sensitive receptors.

Journal: European journal of pharmacology 20030808

Title: Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.

Journal: Proceedings of the National Academy of Sciences of the United States of America 19991123

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:22972-55-0 Molecular Formula|22972-55-0 MDL|22972-55-0 SMILES|22972-55-0 1,3-Benzenediol, 4-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-